PPT-Medication-Related Osteonecrosis of the Jaw (MRONJ)

Author : GoodGirlGoneBad | Published Date : 2022-08-02

Daniel D Skaar DDS MS MBA Spring 2022 Thank you to TePe Oral Health Care Inc for sponsoring AAP Education Access Improve understanding of medicationrelated osteonecrosis

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Medication-Related Osteonecrosis of the ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Medication-Related Osteonecrosis of the Jaw (MRONJ): Transcript


Daniel D Skaar DDS MS MBA Spring 2022 Thank you to TePe Oral Health Care Inc for sponsoring AAP Education Access Improve understanding of medicationrelated osteonecrosis of the jaw MRONJ. . Medication Reconciliation/Transitions of Care. Medication-Focused Transitions of Care Initiatives . . PTA=Prior to Admission. Validation of Prior to Admission Medication (PTA) List. Prior to Admission (PTA) Medication List-Pharmacist Evaluation. . AT KENYATTA NATIONAL HOSPITAL.. Dr Rugendo Birichi A. Dr . Karimi Peter . N. Dr . Amugune Beatrice K. Medication related problems occur when outcome of medicine use is not optimal.. Presented By: . Manessah Cox, Student. Anna Nguyen, Student. What is osteonecrosis of the jaw (ONJ)?. Described as the persistence of exposed bone in the oral cavity. . Results in loss of viability due to lack of blood supply. . . Mary Mckay DNP, ARNP, CNE. . . Jill Sanko, . PhD, MS, ARNP-BC, CHSE-A. Acknowledgement. This research study was supported by a grant from the Florida Blue Foundation. Medication Related Falls Through Appropriate Medication Use. Chanel F. Agness, . PharmD. , Certified Geriatric Pharmacist . cagness@. rx.umaryland.edu. Stephanie . Callinan, . PharmD. , Geriatric . Pharmacy Resident . A Collaborative Approach to Care. January 27, 2018 * Tex-CHIP Training Series. Medical Management of Symptoms. Understanding . Provider. Role in Treating Depression. NURSING – . Levels of Practice. AAE Position Statement The NICO lesion (Neuralgia-Inducing Cavitational Osteonecrosis, also known as Ratner AAE Position Statement IntroductionBisphosphonates are an important class of drugs that have widespread use in managing osteoporosis and treating certain cancers. A recently recognized adverse effect, IntroductionSome medications may cause edema in people who do not normally have swelling. They can also exacerbate swelling in those who already have lymphedema and may be contributing factors in thos JOURNAL OFRESEARCH AND PRACTICEON THE MUSCLOSKELETAL SYSTEM Journal of Research and Practice on the Musculoskeletal System Review Article Physical therapy intervention in early-stage femoral head ost Published March 2017. What is SDCEP?. The Scottish Dental Clinical Effectiveness Programme (SDCEP) is part of the Dental Directorate within NHS Education for Scotland. SDCEP develops guidance on priority topics for oral health care that aims to be evidence-based, practical and user friendly to support quality care. Philip A Routledge. James Coulson. All Wales Therapeutics and Toxicology Centre. Cardiff, Wales, UK. Case Study. A 44 year-old woman had a urinary tract infection and was prescribed the antibiotic nitrofurantoin for 10 days. Two weeks later she noticed numbness, pins and needles and tingling of the lower limbs up to mid-thigh. She was examined by a neurologist three months later, who stated that this was likely to have been a peripheral neuropathy related to the previous course of nitrofurantoin. She is referred to you (as a clinical pharmacologist) for advice.. Andrew Smith, Lancaster, UK. On behalf of the ESAIC Patient Safety and Quality Committee and the EBA. Adverse drug event ADE. “. An adverse drug event, injuries resulting from medical intervention. Chelsea . Sanchez, . PharmD. , BCPS. Disclosure Statement . We do not have any financial or conflict of interest to disclose . . About me . Chelsea Sanchez. PharmD from . Pharmacotherapy Specialty Residency from Texas Tech.

Download Document

Here is the link to download the presentation.
"Medication-Related Osteonecrosis of the Jaw (MRONJ)"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents